Exploring the short-term impact of DNA-testing in breast cancer patients: The counselees' perception matters, but the actual BRCA1/2 result does not

Patient Education and Counseling

Volumn 86, Issue 2, 2012, Pages 239-251

  Vos, Joël ^a   Oosterwijk, Jan C ^b   Gomez Garcia, Encarna ^c   Menko, Fred H ^d   Collee, Margriet J ^e   van Asperen, Christi J ^a   Jansen, Anna M ^a   Stiggelbout, Anne M ^a   Tibben, Aad ^a,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1 2; Breast cancer; Genetic counseling; Oncology; Ovarian cancer; Psychology; Risk perception

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER THERAPY; CONTROLLED STUDY; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; FEMALE; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; THERAPY EFFECT; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MENTAL RECALL; MIDDLE AGED; MODELS, THEORETICAL; PERCEPTION; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK;

EID: 84856230503     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.04.017     Document Type: Article

References (76)

1. Resta R., Biesecker B.B., Bennett R.L., Blum S., Estabrooks Hahn S., Strecker M.N., et al. A new definition of genetic counseling: national society of genetic counselors' task force report. J Genet Couns 2006, 15:77-83.
2. Stratton M., Rahman N. The emerging landscape of breast cancer susceptibility. Nat Genet 2008, 40:17-22.
3. Meiser B., Tucker K., Friedlander M., Barlow-Stewart K., Lobb E., Saunders C., et al. Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res 2008, 10:216-240.
4. Heshka J.T., Palleschi C., Howley H., Wilson B., Wells P.S. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008, 10:19-32.
5. Broadstock M., Michie S., Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000, 8:731-738.
6. Hamilton J.G., Lobel M., Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 2009, 28:510-518.
7. Meiser B., Halliday J.L. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002, 54:1463-1470.
8. Butow P.N., Lobb E.A., Meiser B., Barratt A., Tucker K.M. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 2003, 178:77-81.
9. Braithwaite D., Emery J., Walter F., Prevost A.T., Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer 2006, 5:61-75.
10. Schlich-Bakker K.J., ten Kroode H.F.J., Ausems M.G.E.M. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 2006, 62:13-20.
11. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005, 14:1060-1074.
12. Biesecker B. Adaptation to living with a genetic condition or risk: a mini review. Clin Genet 2008, 74:401-407.
13. Vos J., Otten W., van Asperen C., Jansen A., Menko F., Tibben A. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. Psycho-Oncology 2008, 17:822-830.
14. Vos J, Gomez-Garcia EB, Oosterwijk JC, Menko FH, Stoel RD, Asperen CJv, et al. Opening the psychological black box in genetic counseling. The psychological impact of DNA-testing is predicted by the counsellees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result. Psycho-Oncology, in press.
15. Smerecnik C.M.R., Mesters I., Verweij E., De Vries N.K., de Vries H. A systematic review of the impact of genetic counseling on risk perception accuracy. J Genet Couns 2009, 18:217-228.
16. Sivell S., Elwyn G., Gaff C.L., Clark A.J., Iredale R., Shaw C., et al. How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns 2008, 17:30-63.
17. Katapodi M.C., Lee K.A., Facione N.C., Dodd M.J. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 2004, 38:388-402.
18. Slovic P., Finucane M.L., Peters E., MacGregor D.G. Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk Anal 2004, 24:311-322.
19. van Dijk S., Otten W., van Asperen C.J., Timmermans D.R.M., Tibben A., Zoeteweij M.W., et al. Feeling at risk: how women interpret their familial breast cancer risk. Am J Med Genet A 2004, 131A:42-49.
20. Fischhoff B. Why (cancer) risk communication can be hard. J Natl Cancer Inst Monogr 1999, 25:7-13.
21. Vos J., Oosterwijk J.C., Gomez-Garcia E.B., Menko F.H., Jansen A.M., Stoel R.D., et al. Perceiving cancer-risks and heredity-likelihood in genetic-counseling: the analysis of the counselees' recollections and interpretations of BRCA1/2-test results. Clin Genet 2011, 79:207-218.
22. McAllister M. Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003, 64:179-189.
23. van Dijk S., Otten W., Tollenaar R.A.E.M., van Asperen C.J., Tibben A. Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer. Genet Med 2008, 10:745-750.
24. Park C.L., Folkman S. Meaning in the context of stress and coping. Rev Gen Psychol 1997, 1:115-144.
25. Klein W.M.P., Stefanek M.E. Cancer risk elicitation and communication: lessons from the psychology of risk perception. CA Cancer J Clin 2007, 57:147-167.
26. Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, et al. Genetic testing for familial/hereditary breast cancer - comparison of guidelines and recommendations from the United Kingdom, France, The Netherlands and Germany. J Commun Genet, in press.
27. Netherlands Foundation for the Detection of Hereditary Tumours (STOET), Dutch Society of Clinical Geneticists (VKGN), [Hereditary Tumor Guideline for Diagnostics and Prevention]; 2010. http://www.stoet.nl/uploads/richtlijnenboekje.pdf.
28. Timmermans D.R.M. What clinicians can offer: assessing and communicating probabilities for individual patient decision making. Horm Res 1999, 51:58-66.
29. Ockhuysen-Vermey C.F., Henneman L., van Asperen C.J., Oosterwijk J.C., Menko F.H., Timmermans D.R.M. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling. BMC Cancer 2008, 8:283.
30. Waldron CA, Van der Weijden T, Ludt S, Gallacher J, Elwyn G. What are effective strategies to communicate cardiovascular risk information to patients? A systematic review. Patient Educ Couns, in press.
31. Vadaparampil S.T., Ropka M., Stefanek M.E. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers. Fam Cancer 2005, 4:206.
32. Timman R., Stijnen T., Tibben A. Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review. J Med Genet 2004, 41.
33. Esplen M.J., Stuckless N., Hunter J., Liede A., Metcalfe K., Narod S., et al. The development of a self-concept scale for BRCA1 and BRCA2 carriers. Psycho-Oncology 2000, 9:S4.
34. Coyne J.C., Kruus L., Racioppo M., Calzone K.A., Armstrong K. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?. Am J Med Genet A 2003, 116A:222-228.
35. van Oostrom I., Meijers-Heijboer H., Ladder L.N., Duivenvoorden H.J., van Goal A.R., Seynaeve C., et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003, 21:3867-3874.
36. Thewes B., Meiser B., Tucker K., Schnieden V. Screening for psychological distress and vulnerability factors in women at increased risk for breast cancer: a review of the literature. Psychol Health Med 2003, 8:201.
37. DudokdeWit A.C., Tibben A., Duivenvoorden H.J., Niermeijer M.F., Passchier J. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress?. J Med Genet 1998, 35:745-754.
38. Etchegary H. Psychological aspects of predictive genetic-test decisions: what do we know so far?. Anal Soc Issu Public Policy 2004, 4:13-31.
39. van Oostrom I., MeijersHeijboer E.J., Duivenvoorden H., Brocker-Vriends A., van Asperen C., Sijmons R.H., et al. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psycho-Oncology 2006, 16:320-328.
40. van Oostrom I., Meijers-Heijboer H., Duivenvoorden H.J., Brocker-Vriends A.H.J.T., van Asperen C.J., Sijmons R.H., et al. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006, 17:1090-1095.
41. van Oostrom I., Meijers-Heijboer E.J., Duivenvoorden H., Brocker-Vriends A., van Asperen C., Sijmons R.H., et al. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007, 71:35-42.
42. van Asperen C.J., van Dijk S., Zoeteweij M.W., Timmermans D.R.M., de Bock G.H., Meijers-Heijboer E.J., et al. What do women really want to know? Motives for attending familial breast cancer clinics. J Med Genet 2002, 39:410-414.
43. Kelly K., Leventhal H., Andrykowski M., Toppmeyer D., Much J., Dermody J., et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho-Oncology 2005, 14:34-48.
44. van Oostrom I., Meijers-Heijboer E.J., Duivenvoorden H., Brocker-Vriends A., van Asperen C., Sijmons R.H., et al. The common sense model of self-regulation and psychological adjustment to genetic cancer susceptibility testing: a prospective study. Psycho-Oncology 2007, 16:1121-1129.
45. Anderson G. Storytelling: a holistic foundation for genetic nursing. Holist Nurs Pract 1998, 12:64-76.
46. Baron R.M., Kenny D.A. The moderator mediator variable distinction in social psychological-research - conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986, 51:1173-1182.
47. Anonymous Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996, 14:1730-1736.
48. Frank T.S., Deffenbaugh A.M., Reid J.E., Hulick M., et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002, 20:1480-1490.
49. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67:361-370.
50. Spinhoven P. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997, 27:363-370.
51. Lerman C., Trock B., Rimer B.K., Jepson C., Brody D., Boyce A. Psychological side-effects of breast-cancer screening. Health Psychol 1991, 10:259-267.
52. Horowitz M., Wilner N., Alvarez W. Impact of event scale - measure of subjective stress. Psychosom Med 1979, 41:209-218.
53. Kasparian N.A., Wakefield C.E., Meiser B. Assessment of psychosocial outcomes in genetic counseling research: an overview of avalaible measurement scales. J Genet Couns 2007, 16:712.
54. Esplen M.J., Stuckless N., Hunter J., Liede A., Metcalfe K., Glendon G., et al. The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology 2009, 18:1216-1229.
55. Moss-Morris R., Weinman J., Petrie K.J., Horne R., Cameron L.D., Buick D. The revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002, 17:1-16.
56. Kleijn W.C., Van Heck G.L., Van Waning A. Ervaringen met een Nederlandse bewerking van de COPE copingvragenlijst: De COPE-Easy. Gedrag Gezondheid 2000, 28:213-226. [in Dutch].
57. van Dierendonck D. The construct validity of Ryff's scales of psychological well-being and its extension with spiritual well-being. Pers Individ Differ 2004, 36:629-643.
58. Scheier M.F., Carver C.S., Bridges M.W. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem) - a reevaluation of the life orientation test. J Pers Soc Psychol 1994, 67:1063-1078.
59. Vos J, Jansen AM, Menko FH, van Asperen CJ, Stiggelbout AM, Tibben A. The impact of DNA-test result disclosure on families. Genet Med, in press.
60. Preacher K.J., Hayes AF Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008, 40:879-889.
61. MacKinnon D.P. Introduction to statistical mediation analyses 2008, Lwrence Erlbaum, Taylor & Francis, New York, London.
62. Fritz M.S., MacKinnon D.P. Required sample size to detect the mediated effect. Psychol Sci 2007, 18:233-239.
63. Craddock Lee S.J. Uncertain futures: individual risk and social context in decision-making in cancer screening. Health Risk Soc 2010, 12:101-117.
64. Coyne J.C., Benazon N.R., Gaba C.G., Calzone K., Weber B.L. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. J Consult Clin Psychol 2000, 68:864-874.
65. Benazon N.R., Coyne J.C., Calzone K.A., Weber B.L. Why not to screen high-risk women anticipating BRCA1/BRCA2 testing for psychological distress. J Consult Clin Psychol 2002, 70:258.
66. Palmer S.C., Kagee A., Kruus L., Coyne J.C. Overemphasis of psychological risks of genetic testing may have "dire" consequences. Psychosomatics 2002, 43:86-87.
67. Dorval M., Bouchard K., Maunsell E., Plante M., Chiquette J., Camden S., et al. Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population. J Genet Couns 2008, 17:314-326.
68. Vos J., Jansen A.M., Menko F.H., van Asperen C.J., Stiggelbout A.M., Tibben A. A whisper-game perspective on the family communication of DNA-test results. Fam Cancer 2011, 10:87-96.
69. Kahneman D. A perspective on judgment and choice: mapping bounded rationality. Am Psychol 2003, 58:697-720.
70. Weinstein N.D. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med 1987, 10:481-500.
71. Norem J.K., Cantor N. Defensive pessimism: harnessing anxiety as motivation. J Pers Soc Psychol 1986, 51:1208-1217.
72. Langford I.H. An existential approach to risk perception. Risk Anal 2002, 22:101-120.
73. Lee V., Cohen S.R., Edgar L., Laizner A.M., Gagnon A.J. Clarifying "meaning" in the context of cancer research: a systematic literature review. Palliat Support Care 2004, 2:291-303.
74. Robertson A. Embodying risk, embodying political rationality: women's accounts of risks for breast cancer. Health Risk Soc 2010, 2:219-235.
75. Stam P., Van der Looiu E., Voorendt M., Van der Burgt I., Hoogerbrugge N. Overestimated lifetime cancer risk can be reduced by feedback on preexisting estimation (EP03.03). Eur J Hum Genet 2010, 18:386.
76. Edwards A., Gray J., Clarke A., Dundon J., Elwyn G., Gaff C., et al. Interventions to improve risk communication in clinical genetics: systematic review. Patient Educ Couns 2008, 71:4-25.